Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

(NASDAQ:MBRX), – Live video webcast on Wednesday, February 11th at 1:20 PM EST HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in the Corporate Connect Webinar Series hosted by Webull Financial being held virtually February 10-11, 2026. Details of the presentation […]

Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

(NASDAQ:AKTX), – Live video webcast on Tuesday, February 10th at 1:00 PM EST TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company pioneering next-generation antibody drug conjugates (ADCs) powered by novel RNA-splicing payloads, today announced that it will participate in the Corporate Connect Webinar Series

La Rosa Holdings Corp. Signs Contract to Acquire Development Site for Up to 10,000 Sq. Ft. Tier III AI Data Center in Central Florida’s Fastest-Growing Region

La Rosa Holdings Corp. Signs Contract to Acquire Development Site for Up to 10,000 Sq. Ft. Tier III AI Data Center in Central Florida's Fastest-Growing Region GlobeNewswire February 05, 2026 Celebration, FL, Feb. 05, 2026 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise,

GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial GlobeNewswire February 05, 2026 – Live video webcast on Wednesday, February 11th at 1:00 PM EST LA JOLLA, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing

Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program

Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program GlobeNewswire February 05, 2026 The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines achieving U.S. FDA approval before September 2029 The

Back to the Roots Unveils “Meet Your Farmer” Initiative to Bring More Transparency to the Home Gardening Industry

Back to the Roots Unveils “Meet Your Farmer” Initiative to Bring More Transparency to the Home Gardening Industry Pioneering 'Farm-to-Packet' Transparency: National Organic Leader Reconnects Millions of Home Gardeners to the Source of Their Seeds GlobeNewswire February 05, 2026 OAKLAND, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Back to the Roots, the nation's leading organic

Summit Networks Inc. Announces Revocation of Cease Trade Order

Summit Networks Inc. Announces Revocation of Cease Trade Order GlobeNewswire February 05, 2026 VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) — Summit Networks Inc. (OTCQB: SNTW) (the “Company”) announces that the British Columbia Securities Commission (“BCSC”) has issued an order revoking the cease trade order, originally issued in respect of the securities of Company

Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial GlobeNewswire February 05, 2026 – Live video webcast on Wednesday, February 11th at 1:20 PM EST HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in the

Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial GlobeNewswire February 05, 2026 – Live video webcast on Tuesday, February 10th at 1:00 PM EST TAMPA, Fla. and LONDON, Feb. 05, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company pioneering next-generation antibody drug

LifeZoom Introduces the Oclux Red Light Eye Mask–A Naturally Restorative, Aesthetics-Driven Solution for the Effects of Screen-Based Life

LifeZoom, a natural-restorative brand, today launches Oclux, a red light eye mask that expands the company’s red light product lineup. Positioned as a holistic solution that balances visual aesthetics, user experience, and daily rhythms, Oclux is designed to help relieve the physical and mental imbalances associated with modern lifestyles and to guide users back toward

Scroll to Top